Eden Innovations reports sales growth

Carbon nanotube concrete additive developer, Eden Innovations (ASX: EDE) appears to have made a breakthrough in commercialising its unique technologies, reporting its first significant sales. The company, which developed EdenCrete, a carbon nanotube enriched admixture for concrete, reported sales of $416,000 for the quarter to the end of march, compared to only $19,000 in the…

Reece Pharmaceuticals scales up manufacturing

Synthetic antibiotic developer Recce Pharmaceuticals Ltd (ASX: RCE) has scaled up its Sydney production facility to support its commercialisation activities. The company, which has patented a new class of antibiotics to tackle resistant superbugs, has increased capacity at Macquarie Park in Sydney fivefold to cope with increasing demand. The Company has developed an automated process…